
Global Alpha Dumps $17.9M Ani Pharma Stake Despite Strong Earnings
Global Alpha Capital Management sold $17.9M in Ani Pharmaceuticals shares, reducing position 39%, despite strong 20.5% Q1 sales growth and raised guidance.
ANIPportfolio rebalancingpharmaceutical company